Nancy Hopkins, a professor emerita of biology at MIT, chats with STAT on a new initiative to address gender inequities in biotech….
[mc4wp_form id="449"]
The president of Massachusetts General Hospital, Dr. Peter L. Slavin, plans to step down after 18 years leading the powerful and prestigious…
STAT+: Boston’s hospital chiefs moonlight on corporate boards at rates far beyond the national level
While it remains fairly unusual for hospital chiefs across the country to work as directors for publicly traded companies, the practice is…
The Future Founders Initiative, launched by a group of MIT scientists, calls for collaborations between the university, VC firms, and faculty. Source:…
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium…
Moderna performed a miracle last year: The Cambridge biotech company, which hadn’t put a product on the market since it was founded in 2010, delivered a coronavirus vaccine…
Just over two months after announcing its debut with $108 million in funding, Boston startup Scorpion Therapeutics said Thursday it has raised an even larger amount of venture…
It’s tempting to see Haven as another casualty of entrenched interests in American medicine. But the endeavor, however ambitious, also collided with the equally unmovable aims of Amazon,…
Biologists tend not to discuss experimental results on a handful of cells and a single solitary mouse — too preliminary, too sketchy. David Liu of the Broad Institute…
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium…